[1]
“TARGETING TUMORS WITH NANOVACCINES: A COMPREHENSIVE REVIEW OF IMMUNE ACTIVATION, COMPOSITION, AND THERAPEUTIC STRATEGIES”, rjnmsr, vol. 3, no. 4, pp. 111–120, Aug. 2025, Accessed: Sep. 23, 2026. [Online]. Available: https://nmsreview.org/index.php/rjnmsr/article/view/296